Friday, November 13, 2026

Dollar Index Drops 10.8% as Euro Surges 14% in Global Currency Rebalancing

The US Dollar Index fell 10.8% in the first half of 2025 as the Euro gained 14% and the British Pound rose 7%, marking a major currency rebalancing across global markets. The shift coincides with Federal Reserve chair Jerome Powell's impending departure, creating uncertainty around US monetary policy direction. Currency volatility is expected to persist as traders position for potential policy changes under new Fed leadership.

LM Salvado
LM Salvado

March 21, 2026

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
Dollar Index Drops 10.8% as Euro Surges 14% in Global Currency Rebalancing
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US Dollar Index fell 10.8% in the first half of 2025 as major currencies rallied against the greenback in a global rebalancing.1 The Euro surged 14% during the period while the British Pound advanced 7%, reflecting shifting expectations for Federal Reserve policy as Jerome Powell prepares to step down.1

The currency moves signal a fundamental shift in how global markets view US monetary policy. Dollar weakness accelerated as Powell's tenure nears its end, with traders positioning for potential policy changes under new leadership.1 The Bank of Canada and other central banks maintained cautious stances as currency volatility increased across developed economies.1

The pound traded at $1.3086 in late November, down 0.5% on the day, with currency traders closely monitoring the $1.30 level as key technical support.13 against the euro, hitting its lowest level since April 2023.EUR/USD benefited most from the 14% euro appreciation, while GBP/USD's 7% gain reflects both dollar weakness and UK-specific factors including fiscal policy concerns.1

Simon Phillips, Managing Director at No1 Currency, noted the pound remains under pressure despite year-to-date gains.4 The pattern suggests global currencies are recalibrating against the dollar as markets digest Fed transition developments and central bank policy divergence across major economies.

Technical analysts note the dollar index has stabilized after its initial 10.8% drop, but recovery remains fragile.1 The forex market continues pricing in uncertainty around US monetary policy direction, keeping pressure on the dollar across major pairs while global traders monitor key technical levels for positioning opportunities.5rem 0;">Related Coverage

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 18, 2026
    Fed meeting live updates: Federal Reserve expected to hold rates steady, share outlook amid Iran oil shock
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· March 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq rise for second day in a row with Fed decision on deck

In this story · Knowledge Files

Categories

Tags

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com